These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16049723)

  • 1. [Aftercare or not--that is the question!].
    Schubert-Fritschle G; Weissbach L; Hölzel D
    Urologe A; 2005 Sep; 44(9):991-6. PubMed ID: 16049723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aftercare of urological tumors---why and how?].
    Weissbach L; Dieckmann KP
    Urologe A; 2005 Sep; 44(9):989-90. PubMed ID: 16044282
    [No Abstract]   [Full Text] [Related]  

  • 3. [Penile cancer--aftercare with results. How much is necessary?].
    Paul R; van Randenborgh H; Schöler S; May F; Hartung R
    Urologe A; 2005 Sep; 44(9):1031-6. PubMed ID: 16075197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aftercare in testicular cancer is worthwhile. Recurrences are curable].
    Pottek TS; Dieckmann KP
    Urologe A; 2005 Sep; 44(9):1024-30. PubMed ID: 16075198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The aftercare principle for metastasizing prostate cancer. Few diagnostics, much support].
    Heine K; Wolff JM
    Urologe A; 2005 Sep; 44(9):1009-12, 1014-7. PubMed ID: 16096743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [When is aftercare useful in renal cell cancer?].
    Ebert T; Fischer C
    Urologe A; 2005 Sep; 44(9):1018, 1020-3. PubMed ID: 16047197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary prevention after urological cancers. What are the pertinent facts about aftercare?].
    Schroeder A
    Urologe A; 2007 Jun; 46(6):642-5. PubMed ID: 17447048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy for systemic urothelial cancer recurrence].
    Lehmann J; Stöckle M
    Urologe A; 2005 Apr; 44(4):369-74. PubMed ID: 15754166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of tumor-recurrences--only the second best choice].
    Gschwend JE
    Urologe A; 2005 Apr; 44(4):351. PubMed ID: 15703890
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aftercare, symptomatic and terminal care of cancer patients in medical primary care].
    Hartung GH
    Z Arztl Fortbild (Jena); 1983; 77(13):560-3. PubMed ID: 6194624
    [No Abstract]   [Full Text] [Related]  

  • 11. [PSA recurrence after primary curative therapy--local or systemic? When is a second curative therapy still possible?].
    Wirth MP; Engelhardt FM
    Urologe A; 2005 Sep; 44(9):997-1004, 1006-7. PubMed ID: 16133232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Follow-up of urological tumor treatment].
    Ohlmann CH; Albers P; Boehm K; Graefen M; Hakenberg OW; Kuczyk M; Graf J; Peters I; Protzel C
    Urologe A; 2015 Sep; 54(9):1223-33. PubMed ID: 26246111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Palliative treatment of terminal cancer patients].
    Pichlmaier H; Thielemann-Jonen I; Zech D
    Internist (Berl); 1988 Jan; 29(1):26-33. PubMed ID: 2450852
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differential after care for early detection of recurrence--from the general practice viewpoint].
    Rehner M
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():247-9. PubMed ID: 1983558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pain and symptom management in palliative care].
    Gaertner J; Voltz R; Golla H; Ostgathe C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Nov; 49(11):1097-103. PubMed ID: 17072512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of the melanoma patient.
    Deschner B; Wayne JD
    J Surg Oncol; 2019 Jan; 119(2):262-268. PubMed ID: 30548539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality in urology].
    Miller K
    Urologe A; 2016 Sep; 55(9):1163. PubMed ID: 27514388
    [No Abstract]   [Full Text] [Related]  

  • 18. [Guidelines: reality and quality].
    Rogenhofer S; Zengerling F; Schrader M; Müller SC
    Urologe A; 2012 Aug; 51(8):1074-7. PubMed ID: 22801814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of testicular cancer].
    Krege S; Hartmann JT; Rübben H
    Urologe A; 2006 May; 45(5):600-4. PubMed ID: 16612645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local recurrence following radical cystectomy for bladder cancer. Diagnostic and therapeutic options].
    Simon J; Gschwend JE; Volkmer BG
    Urologe A; 2005 Apr; 44(4):375-81. PubMed ID: 15750678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.